|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
19 October 2017 |
|
Main ID: |
NCT01879735 |
|
Date of registration:
|
11/06/2013 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Biliary Excretion of Conjugated Bile Acids in Humans Measured by 11C-cholylsarcosine PET/CT
|
|
Scientific title:
|
Hepatic Transport of Conjugated Bile Acids in Humans Quantified by 11C-cholylsarcosine PET/CT |
|
Date of first enrolment:
|
June 2013 |
|
Target sample size:
|
22 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT01879735 |
|
Study type:
|
Interventional |
|
Study design:
|
|
|
Phase:
|
Phase 1
|
|
|
Countries of recruitment
|
|
Denmark
| | | | | | | |
|
Contacts
|
|
Name:
|
Susanne Keiding, M.D. D.Sc. |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Aarhus University Hospital |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Patients with cholestatic disorders and healthy subjects
Exclusion Criteria:
- Body weight above 110 kg (catheterization problematic).
- Diabetes
- Pregnant or breast feeding women.
Age minimum:
18 Years
Age maximum:
N/A
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Primary Sclerosing Cholangitis
|
|
Cholestasis
|
|
Primary Biliary Cirrhosis
|
|
Intervention(s)
|
|
Drug: 11C-CSar
|
|
Drug: ICG
|
|
Primary Outcome(s)
|
|
Percentage of Participants in Whom we Could Quantify Hepatic Transport of 11C-CSar
[Time Frame: All measurements are performed in one day.]
|
|
Secondary ID(s)
|
|
C-CSar humane 244
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|